Guest guest Posted February 11, 2010 Report Share Posted February 11, 2010 info - The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective http://www3.interscience.wiley.com/journal/123278857/abstract?CRETRY=1 & SRETRY=0 Alana Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.